• Clinical Update

    Molecularly Targeted Cancer Drugs and Ocular Toxicity

    Written By: Lori Baker-Schena, MBA, EdD, interviewing M. Tariq Bhatti, MD, Frederick W. Fraunfelder, MD, MBA, and April K.S. Salama, MD

    Molecularly targeted cancer drugs are revolutionizing oncology—and raising the risk of new ocular side effects. An overview.